BARC develops indigenous Ruthenium 106 Plaque to treat eye cancer
BARC develops indigenous Ruthenium 106 Plaque to treat eye cancer
29 December 2020 | News The handling of plaque is very convenient for the surgeon and it has been acknowledged to be at par with the international standards
Source credit: Shutterstock
Dr Jitendra Singh, Union Minister of State (Independent Charge) Development of North Eastern Region (DoNER), MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space has lauded the Bhabha Atomic Research Centre (BARC) Mumbai for developing Eye Cancer therapy in the form of the first indigenous Ruthenium 106 Plaque for treatment of Ocular Tumours. The handling of plaque is very convenient for the surgeon and it has been acknowledged to be at par with the international standards.